Building a Canadian CDMO from grad school
About this episode
The episode features an interview with Lisa Studnicki Hunt discussing her journey in building a Canadian CDMO from grad school.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Lisa Studnicki Hunt, Ph.D, Co-Founder and Board Member, GL CHEMTEC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lisa, covering: How her passion for problem solving led her to cofound a CDMO straight out of grad school How, without an established industry network, she focused on developing her core skill set and immersing herself in a different culture Figuring things out day by day, while pursuing opportunities aligned with the company’s long term vision Positioning the business as “innovation experts” to differentiate in a competitive and fragmented CRO and CDMO market How the pandemic accelerated demand and growth, ultimately leading to a well timed private equity deal The “misbehaving of the market” over the last few years, and how a Canadian CDMO is positioned amid geopolitical shifts involving the US and China Lisa co-founded GL CHEMTEC INTERNATIONAL in 2002 and has played a key role in growing the organization across both operations and commercial functions for more than two decades. She also now serves on…
More episodes of Molecule to Market: Inside the outsourcing space
Explore listener stats, chart rankings, contacts and more on the Molecule to Market: Inside the outsourcing space podcast page.